StockData
Caribou Biosciences, Inc. logo

Caribou Biosciences, Inc. (CRBU) stock

CRBUNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3073% below fair value
$0.35−0.01 (-2.51%)

Close on Nov 16, 2026Market cap $37.82MP/E –Yield –

Caribou Biosciences operating margin

Operating margin is operating income as a percentage of revenue.

Caribou Biosciences's operating margin for the twelve months ending Jun 30, 2026 was -1090.9%. For fiscal 2025 it was -1329.4%, against -1667.2% the year before. The highest annual figure on record is -292.2% in fiscal 2020.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-1329.4%+337.8
FY2024Dec 31, 2024-1667.2%−1330.5
FY2023Dec 31, 2023-336.6%+431.5
FY2022Dec 31, 2022-768.2%−70.3
FY2021Dec 31, 2021-697.8%−405.6
FY2020Dec 31, 2020-292.2%+300.5
FY2019Dec 31, 2019-592.7%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-1690.4%+93.6
Q1 FY2026Mar 31, 2026-1096.4%+727.4
Q4 FY2025Dec 31, 2025-722.0%+1149.7
Q3 FY2025Sep 30, 2025-1337.6%+551.6
Q2 FY2025Jun 30, 2025-1784.0%−528.1
Q1 FY2025Mar 31, 2025-1823.8%+70.1
Q4 FY2024Dec 31, 2024-1871.7%−819.4
Q3 FY2024Sep 30, 2024-1889.2%−1827.4
Q2 FY2024Jun 30, 2024-1255.8%−380.5
Q1 FY2024Mar 31, 2024-1893.9%−1005.3
Q4 FY2023Dec 31, 2023-1052.3%−224.1
Q3 FY2023Sep 30, 2023-61.8%+741.6
Q2 FY2023Jun 30, 2023-875.3%−197.1
Q1 FY2023Mar 31, 2023-888.5%−105.8
Q4 FY2022Dec 31, 2022-828.2%−30.8
Q3 FY2022Sep 30, 2022-803.4%−335.3
Q2 FY2022Jun 30, 2022-678.2%+403.4
Q1 FY2022Mar 31, 2022-782.8%+47.9
Q4 FY2021Dec 31, 2021-797.4%+748.5
Q3 FY2021Sep 30, 2021-468.1%+218.8
Q2 FY2021Jun 30, 2021-1081.6%−1055.0
Q1 FY2021Mar 31, 2021-830.7%−217.6
Q4 FY2020Dec 31, 2020-1545.8%–
Q3 FY2020Sep 30, 2020-686.9%–
Q2 FY2020Jun 30, 2020-26.6%–
Q1 FY2020Mar 31, 2020-613.1%–

More Caribou Biosciences figures

See a number that looks wrong?